Is KADCYLA a chemo drug?

Is KADCYLA a chemo drug?

Kadcyla is a combination of Herceptin and a chemo drug that work together to keep cancer cells from growing. It’s already approved by the US Food and Drug Administration to treat women with HER2 positive breast cancer that has metastacized (spread).

Is Herceptin chemotherapy?

Herceptin is an intravenous drug that is part of a chemotherapy regimen that is used to prevent recurrence of breast cancer, and for the treatment breast cancer that has spread beyond the breast (metastasized). It belongs to a class of drugs called monoclonal antibodies.

Do you lose hair with KADCYLA?

Hair loss usually starts after your first or second treatment. It is almost always temporary, and your hair will usually grow back after treatment finishes.

Does KADCYLA weaken immune system?

This treatment affects the immune system. This may cause inflammation in different parts of the body which can cause serious side effects. They could happen during treatment, or some months after treatment has finished. In some people, these side effects could be life threatening.

What is the success rate of KADCYLA?

The researchers estimated 3-year disease-free survival rates to be: 88.3% for people treated with Kadcyla. 77.0% for people treated with Herceptin.

Can you drink alcohol on Kadcyla?

You may feel tired or dizzy after your treatment. What NOT to DO while on this medication: DO NOT smoke or drink alcohol while on treatment without talking to your health care team first. Smoking and drinking can make side effects worse and make your treatment not work as well.

Where can I get more information about Kadcyla?

You may contact Genentech by calling 1-888-835-2555. You may contact the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. Talk to a healthcare professional for more information about the benefits and risks of KADCYLA.

What are the side effects of Kadcyla for cancer?

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects. Common Kadcyla side effects may include: easy bruising or bleeding (especially nosebleeds); nausea, constipation; joint or muscle pain; headache; or. feeling tired.

Which is the latest version of Catzilla benchmark?

In the latest version, we have drawn conclusions from several years of previous experience and conversations with users. The presentation of test results became more simple, which at the moment are easy to read not only by professionals but also by ordinary computer users.

When to use Kadcyla in place of trastuzumab?

Kadcyla is used to treat a certain type of breast cancer that has spread to other parts of the body. Kadcyla is usually given after other cancer medications have been tried without success. Kadcyla (ado-trastuzumab) should not be used in place of Herceptin (trastuzumab).